Price rises drive Moldova's pharma market growth

Retail pharmaceutical sales in Moldova grew by almost 60% to $49.6 million in the first six months of this year, while the number of packs sold increased by 10%, reports Business-Credit, a Kiev-based market research firm. Imported products represented the overwhelming majority (96%) of all medicines on the market, with sales of $47.7 million (+58%).

More from Drug Pricing

More from Scrip